Search research articles
Contact Us
Filters
Showing results (761-770 of 792) with videos related to
Page
of 80
Sort By:
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
October 25, 2021
Recommendations for antibiotic selection for severe nosocomial infections
J Mensa, J Barberán, R Ferrer, et al.
British Journal of Haematology
|
January 14, 2025
Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow-up of vacuolization and UBA1 clonal dynamics
Jose R Álamo, Lucía Mont-de Torres, Sandra Castaño-Díez, et al.
Infectious Diseases and Therapy
|
March 15, 2024
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination
Timothy E Albertson, Caitlin Hansen, Smiti Bihari, et al.
Nature Communications
|
November 15, 2017
mTOR intersects antibody-inducing signals from TACI in marginal zone B cells
Jordi Sintes, Maurizio Gentile, Shuling Zhang, et al.
Trials
|
December 14, 2021
Safety and efficacy of the new CryoPop® cryotherapy device for cervical dysplasia in low- and middle-income countries: study protocol for a multicenter open-label non-inferiority clinical trial with historical controls
S Yogeshkumar, Jean Anderson, Enriquito Lu, et al.
Science Advances
|
August 21, 2024
A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors
Christoph Schultheiß, Lisa Paschold, Alma Nazlie Mohebiany, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 21, 2026
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old
Patricia Winokur, Oyeniyi Diya, David Fitz-Patrick, et al.
Cell
|
February 17, 2024
A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease
Adam Zuiani, Charles L Dulberger, Nilushi S De Silva, et al.
The New England Journal of Medicine
|
January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years
Patricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
Nature
|
February 21, 2024
Making cities mental health friendly for adolescents and young adults
Pamela Y Collins, Moitreyee Sinha, Tessa Concepcion, et al.
Page
of 80
Search research articles
Search
Showing results (761-770 of 792) with videos related to
Sort By:
Page
of 80
Revista Espanola De Quimioterapia : Publicacion Oficial De La Sociedad Espanola De Quimioterapia
|
October 25, 2021
Recommendations for antibiotic selection for severe nosocomial infections
J Mensa, J Barberán, R Ferrer, et al.
British Journal of Haematology
|
January 14, 2025
Hypomethylating agents for patients with VEXAS without myelodysplastic syndrome: Clinical outcome and longitudinal follow-up of vacuolization and UBA1 clonal dynamics
Jose R Álamo, Lucía Mont-de Torres, Sandra Castaño-Díez, et al.
Infectious Diseases and Therapy
|
March 15, 2024
Serum Troponin I Assessments in 5- to 30-Year-Olds After BNT162b2 Vaccination
Timothy E Albertson, Caitlin Hansen, Smiti Bihari, et al.
Nature Communications
|
November 15, 2017
mTOR intersects antibody-inducing signals from TACI in marginal zone B cells
Jordi Sintes, Maurizio Gentile, Shuling Zhang, et al.
Trials
|
December 14, 2021
Safety and efficacy of the new CryoPop® cryotherapy device for cervical dysplasia in low- and middle-income countries: study protocol for a multicenter open-label non-inferiority clinical trial with historical controls
S Yogeshkumar, Jean Anderson, Enriquito Lu, et al.
Science Advances
|
August 21, 2024
A20 haploinsufficiency disturbs immune homeostasis and drives the transformation of lymphocytes with permissive antigen receptors
Christoph Schultheiß, Lisa Paschold, Alma Nazlie Mohebiany, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
January 21, 2026
Safety and Immunogenicity of a Fourth Dose of Omicron-BA.1-Adapted BNT162b2 COVID-19 Vaccines in Adults 18‒55 Years Old
Patricia Winokur, Oyeniyi Diya, David Fitz-Patrick, et al.
Cell
|
February 17, 2024
A multivalent mRNA monkeypox virus vaccine (BNT166) protects mice and macaques from orthopoxvirus disease
Adam Zuiani, Charles L Dulberger, Nilushi S De Silva, et al.
The New England Journal of Medicine
|
January 18, 2023
Bivalent Omicron BA.1-Adapted BNT162b2 Booster in Adults Older than 55 Years
Patricia Winokur, Juleen Gayed, David Fitz-Patrick, et al.
Nature
|
February 21, 2024
Making cities mental health friendly for adolescents and young adults
Pamela Y Collins, Moitreyee Sinha, Tessa Concepcion, et al.
Page
of 80